- Home
- INDO vs CRIS Comparison
INDO vs CRIS Comparison
Compare INDO & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDO
- CRIS
- Stock Information
- Founded
- INDO 2018
- CRIS 2000
- Country
- INDO Indonesia
- CRIS United States
- Employees
- INDO N/A
- CRIS N/A
- Industry
- INDO Oil & Gas Production
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INDO Energy
- CRIS Health Care
- Exchange
- INDO Nasdaq
- CRIS Nasdaq
- Market Cap
- INDO 35.1M
- CRIS 21.3M
- IPO Year
- INDO 2019
- CRIS 2000
- Fundamental
- Price
- INDO $2.86
- CRIS $1.80
- Analyst Decision
- INDO
- CRIS Strong Buy
- Analyst Count
- INDO 0
- CRIS 2
- Target Price
- INDO N/A
- CRIS $16.50
- AVG Volume (30 Days)
- INDO 6.2M
- CRIS 179.9K
- Earning Date
- INDO 07-22-2025
- CRIS 07-31-2025
- Dividend Yield
- INDO N/A
- CRIS N/A
- EPS Growth
- INDO N/A
- CRIS N/A
- EPS
- INDO N/A
- CRIS N/A
- Revenue
- INDO $2,667,508.00
- CRIS $11,202,000.00
- Revenue This Year
- INDO N/A
- CRIS N/A
- Revenue Next Year
- INDO N/A
- CRIS $10.67
- P/E Ratio
- INDO N/A
- CRIS N/A
- Revenue Growth
- INDO N/A
- CRIS 14.17
- 52 Week Low
- INDO $2.06
- CRIS $1.02
- 52 Week High
- INDO $7.95
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- INDO 44.51
- CRIS 42.69
- Support Level
- INDO $2.80
- CRIS $1.70
- Resistance Level
- INDO $3.07
- CRIS $2.01
- Average True Range (ATR)
- INDO 0.22
- CRIS 0.21
- MACD
- INDO -0.10
- CRIS -0.03
- Stochastic Oscillator
- INDO 7.90
- CRIS 38.78
About INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.